- Description
- 1 online resource (iii, 44 pages)
- Subject
- Genre/Form
- Legislative hearings.
- Note
- Access ID (govinfo): CHRG-117hhrg44686.
- "Serial no. 117-23."
- Event (note)
- Date of hearing: 2021-05-19.
- Source of Description (note)
- Description based on online resource; title from PDF title page (govinfo, viewed July 12, 2021).
- Call Number
- GPO Internet Y 4.OV 2:117-23
- LCCN
- 44-686
- OCLC
- marcive1259692367
- Author
United States. Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis, author.
- Title
Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021.
- Publisher
Washington : U.S. Government Publishing Office, 2021.
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- Performer
Hearing witnesses: Mr. Robert G. Kramer, President and Chief Executive Officer, Emergent BioSolutions, Inc.; Mr. Faud El-Hibri, Executive Chairman of the Board of Directors, Emergent BioSolutions, Inc..
- Event
Date of hearing: 2021-05-19.
- Connect to:
- Other Form:
Print version: United States. Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis. Examining Emergent Biosolutions' failure to protect public health and public funds (OCoLC)1259692314
- Other Standard Identifier
44-686 (GPO jacket number)
- Gpo Item No.
1016-C (online)
- Sudoc No.
Y 4.OV 2:117-23